pravastatin has been researched along with Body Weight in 32 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (9.38) | 18.7374 |
| 1990's | 7 (21.88) | 18.2507 |
| 2000's | 9 (28.13) | 29.6817 |
| 2010's | 12 (37.50) | 24.3611 |
| 2020's | 1 (3.13) | 2.80 |
| Authors | Studies |
|---|---|
| Grime, K; Paine, SW | 1 |
| Gari, M; Kumar Mariappan, A; Kumar, A; Kumar, D; Kumar, T; Lingaraju, MC; Parida, S; Rana, A; Sharma, M; Singh, TU | 1 |
| Favero, BC; García-Arevalo, M; Gomes-Marcondes, MCC; Lorza-Gil, E; Oliveira, HCF | 1 |
| Beck, B; Donner, D; du Toit, EF; Headrick, JP; Oi, M; Peart, J; Wendt, L | 1 |
| Marrion, NV; Robertson, JD; Robinson, ES; Stuart, SA | 1 |
| Costantine, MM; Gamble, P; Hankins, GD; Kechichian, T; Longo, M; McDonnold, M; Saade, GR; Tamayo, E | 1 |
| Carraway, JW; Gazda, LS; Hall, RD; Laramore, MA; Smith, BH; Vinerean, HV | 2 |
| Fledderus, JO; Giles, RH; Gremmels, H; Joles, JA; Oosterhuis, NR; Papazova, DA; van Koppen, A; Verhaar, MC | 1 |
| Araki, K; Kakuma, T; Katsuragi, I; Masaki, T; Yoshimatsu, H | 1 |
| Ishihara, Y; Kohno, M; Kosaka, H; Mizukawa, M; Noma, T; Obayashi, A; Ohmori, K; Yoshida, J; Yukiiri, K | 1 |
| Bang, YJ; Byun, HJ; Kim, W; Lee, HS; Lee, SH; Lee, SM; Myung, SJ; Yang, JI; Yoon, JH | 1 |
| Egawa, T; Hirabara, Y; Ikeda, M; Kataoka, Y; Kusaba, K; Mitsunaga, D; Shuto, H; Takano, Y; Tominaga, K; Yamauchi, A | 1 |
| Kückelhaus, CS; Kückelhaus, SA; Muniz-Junqueira, MI | 1 |
| Arai, H; Minami, M; Murayama, T; Tamura, Y; Yokode, M | 1 |
| Chang, NC; Chou, TF; Lee, TM; Lin, MS; Tsai, CH | 1 |
| Bouchier-Hayes, D; Casey, RG; Chen, G; Joyce, M; Roche-Nagle, G | 1 |
| Ichihara, K; Kanda, M; Kasai, T; Keimatsu, N; Satoh, K; Sun, F; Takaguri, A | 1 |
| Hamano, K; Ito, H; Kobayashi, T; Li, TS; Mikamo, A; Suzuki, R; Takahashi, M | 1 |
| Bardou, M; Dumas, M; Goirand, F; Guerard, P; Lirussi, F; Rakotoniaina, Z; Rochette, L | 1 |
| Aizawa, R; Fukaura, Y; Hasebe, M; Ito, M; Morotomi, M; Narisawa, T | 1 |
| do Nascimento, LO; Maranhão e Pesquisadores, RC; Santos, RD | 1 |
| Albarrán, OG; García-Robles, R; Rábano, A; Ruilope, LM; Villa, E | 1 |
| Maranhão, RC; Santos, RD | 1 |
| Bak, AA; Grobbee, DE; Huizer, J; Leijten, PA; Rila, H | 1 |
| Asenjo-Barrón, JC; Cárdenas-Vázquez, R; Díaz-Zagoya, JC; Juárez-Oropeza, MA; Martínez, F | 1 |
| Beinlich, CJ; Ichihara, K; Morgan, HE; Satoh, K; Shirota, F; Tsunajima, T | 1 |
| Arita, S; Kasraie, A; Mullen, Y; Ohtsuka, S; Smith, CV; Une, S | 1 |
| Arbeeny, CM; Bergquist, KE | 1 |
| Manabe, S; Masuda, H; Matsunuma, N; Miyakoshi, N; Sudo, S; Yamashita, K | 1 |
| Manabe, S; Masuda, H; Matsunuma, N; Miyakoshi, N; Sudo, S; Tanase, H; Yamashita, K | 1 |
| Masuda, H; Matsunuma, N; Miyakoshi, N; Tarumi, C; Yamashita, K | 1 |
1 trial(s) available for pravastatin and Body Weight
| Article | Year |
|---|---|
Diet and pravastatin in moderate hypercholesterolaemia: a randomized trial in 215 middle-aged men free from cardiovascular disease.
Topics: Anticholesteremic Agents; Blood Pressure; Body Weight; Combined Modality Therapy; Double-Blind Method; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lipids; Male; Middle Aged; Patient Compliance; Pravastatin; Treatment Outcome | 1998 |
31 other study(ies) available for pravastatin and Body Weight
| Article | Year |
|---|---|
Species differences in biliary clearance and possible relevance of hepatic uptake and efflux transporters involvement.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Bile; Body Weight; Dogs; Drug Administration Routes; Humans; Liver; Membrane Transport Proteins; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Organic Anion Transporters; Pharmaceutical Preparations; Protein Binding; Rats; Species Specificity | 2013 |
Pravastatin attenuates isoprenaline induced cardiac fibrosis in a mouse model.
Topics: Animals; Body Weight; Collagen; Fibrosis; Isoproterenol; Mice; Pravastatin; Transforming Growth Factor beta | 2023 |
Diabetogenic effect of pravastatin is associated with insulin resistance and myotoxicity in hypercholesterolemic mice.
Topics: Animals; Apoptosis; Blood Glucose; Body Weight; Cell Line; Diabetes Mellitus, Experimental; Fasting; Female; Glucose Intolerance; Homeostasis; Hypercholesterolemia; Insulin; Insulin Resistance; Insulin Secretion; Mice, Inbred C57BL; Models, Biological; Muscle Fibers, Skeletal; Muscle Proteins; Myotoxicity; Oxidative Stress; Phosphorylation; Pravastatin; Proteolysis; Receptors, LDL; Signal Transduction; Superoxides | 2019 |
Pravastatin improves risk factors but not ischaemic tolerance in obese rats.
Topics: Animals; Blood Glucose; Body Weight; Diet, Carbohydrate Loading; Diet, High-Fat; Disease Models, Animal; Heart; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertriglyceridemia; Insulin Resistance; Lipid Peroxidation; Male; Mitochondria; Mitochondrial Dynamics; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Obesity; Pravastatin; Rats; Rats, Wistar; Risk Factors | 2018 |
Chronic pravastatin but not atorvastatin treatment impairs cognitive function in two rodent models of learning and memory.
Topics: Animals; Atorvastatin; Body Weight; Cholesterol; Cognition; Discrimination, Psychological; Heptanoic Acids; Male; Memory; Pravastatin; Pyrroles; Rats; Reversal Learning; Time Factors | 2013 |
The effect of prenatal pravastatin treatment on altered fetal programming of postnatal growth and metabolic function in a preeclampsia-like murine model.
Topics: Analysis of Variance; Animals; Area Under Curve; Blood Glucose; Body Weight; Cell Cycle Proteins; Disease Models, Animal; Female; Fetal Development; Insulin; Male; Mice; Pravastatin; Pre-Eclampsia; Pregnancy; Receptors, G-Protein-Coupled; Vascular Endothelial Growth Factor Receptor-1 | 2014 |
Pravastatin improves glucose regulation and biocompatibility of agarose encapsulated porcine islets following transplantation into pancreatectomized dogs.
Topics: Animals; Anticholesteremic Agents; Area Under Curve; Blood Glucose; Body Weight; C-Peptide; Diabetes Mellitus, Experimental; Dogs; Insulin; Islets of Langerhans; Islets of Langerhans Transplantation; Male; Pancreas; Pravastatin; Sepharose; Swine; Time Factors; Transplantation, Heterologous | 2014 |
No evidence of viral transmission following long-term implantation of agarose encapsulated porcine islets in diabetic dogs.
Topics: Animals; Body Weight; C-Peptide; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Dogs; Insulin; Islets of Langerhans; Male; Pravastatin; Sepharose; Swine; Time Factors | 2014 |
Ex vivo exposure of bone marrow from chronic kidney disease donor rats to pravastatin limits renal damage in recipient rats with chronic kidney disease.
Topics: Animals; Apoptosis; Blood Pressure; Body Weight; Bone Marrow Cells; Bone Marrow Transplantation; Cell Movement; Chemokine CXCL5; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Glomerular Filtration Rate; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney; Male; Pravastatin; Rats; Rats, Inbred Lew; Renal Insufficiency, Chronic; Tissue Donors; Transplantation, Homologous | 2015 |
Effects of pravastatin on obesity, diabetes, and adiponectin in diet-induced obese mice.
Topics: Adiponectin; Adipose Tissue, Brown; Adipose Tissue, White; Animals; Blood Glucose; Body Weight; Diabetes Mellitus; Eating; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin; Male; Mice; Mice, Inbred C57BL; Muscle, Skeletal; Obesity; Oxygen Consumption; Pravastatin; Random Allocation; Resistin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Triglycerides | 2008 |
Effects of combined olmesartan and pravastatin on glucose intolerance and cardiovascular remodeling in a metabolic-syndrome model.
Topics: Adiponectin; Adipose Tissue, White; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Glucose; Blood Pressure; Blotting, Western; Body Weight; Cardiovascular System; Drug Therapy, Combination; Eating; Glucose Intolerance; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Imidazoles; Lipids; Male; Metabolic Syndrome; Nitric Oxide Synthase Type III; Oxidation-Reduction; Pravastatin; Rats; Rats, Inbred OLETF; RNA, Messenger; Superoxides; Tetrahydrofolate Dehydrogenase; Tetrazoles | 2009 |
Synergistic antifibrotic efficacy of statin and protein kinase C inhibitor in hepatic fibrosis.
Topics: Animals; Apoptosis; Body Weight; Carbon Tetrachloride; Cell Line, Transformed; Disease Models, Animal; Drug Synergism; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Liver Cirrhosis; Male; Mice; Mice, Inbred BALB C; Mitochondria; Organ Size; Pravastatin; Protein Kinase C; Protein Kinase Inhibitors; Thioacetamide | 2010 |
The statins fluvastatin and pravastatin exert anti-flushing effects by improving vasomotor dysfunction through nitric oxide-mediated mechanisms in ovariectomized animals.
Topics: Animals; Arteries; Body Weight; Estrogen Replacement Therapy; Fatty Acids, Monounsaturated; Female; Fluvastatin; Hot Flashes; Indoles; Menopause; Mice; Nitric Oxide; Organ Size; Ovariectomy; Physical Conditioning, Animal; Pravastatin; Rats; Skin; Uterus; Vasoconstriction; Vasodilation; Vasomotor System | 2011 |
Influence of long-term treatment with pravastatin on the survival, evolution of cutaneous lesion and weight of animals infected by Leishmania amazonensis.
Topics: Analysis of Variance; Animals; Antiprotozoal Agents; Body Weight; Cricetinae; Disease Models, Animal; Disease Susceptibility; Dose-Response Relationship, Drug; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Leishmania mexicana; Leishmaniasis, Cutaneous; Male; Mesocricetus; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Pravastatin; Statistics, Nonparametric; Survival Rate | 2011 |
Differential effect of statins on diabetic nephropathy in db/db mice.
Topics: Adiposity; Albuminuria; Animals; Blood Pressure; Body Weight; Creatinine; Diabetic Nephropathies; Fluorobenzenes; Insulin Resistance; Male; Mice; Oxidative Stress; Pravastatin; Pyrimidines; Quinolines; Real-Time Polymerase Chain Reaction; Rosuvastatin Calcium; Sulfonamides | 2011 |
Effect of pravastatin on development of left ventricular hypertrophy in spontaneously hypertensive rats.
Topics: Animals; Body Weight; Cardiac Pacing, Artificial; Endothelin-1; Hemodynamics; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hypertrophy, Left Ventricular; Immunohistochemistry; Male; Myocardium; Organ Size; Pravastatin; Rats; Rats, Inbred SHR; RNA, Messenger; Ventricular Function | 2005 |
Pravastatin modulates early diabetic nephropathy in an experimental model of diabetic renal disease.
Topics: Animals; Blood Glucose; Body Weight; Cholesterol; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Glomerular Filtration Rate; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Pravastatin; Proteinuria; Rats; Rats, Sprague-Dawley; Renal Circulation; Renal Insufficiency; Triglycerides; Urine | 2005 |
HMG-CoA reductase inhibitors do not improve glucose intolerance in spontaneously diabetic Goto-Kakizaki rats.
Topics: Animals; Atorvastatin; Blood Glucose; Body Weight; Cholesterol; Diabetes Mellitus; Glucose Intolerance; Glucose Tolerance Test; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin; Insulin Resistance; Male; Pravastatin; Pyrroles; Rats; Rats, Wistar; Simvastatin | 2005 |
Pravastatin improves remodeling and cardiac function after myocardial infarction by an antiinflammatory mechanism rather than by the induction of angiogenesis.
Topics: Angiogenesis Inducing Agents; Animals; Anti-Inflammatory Agents, Non-Steroidal; Body Weight; Bone Marrow Cells; Bone Marrow Transplantation; Cell Differentiation; Cells, Cultured; Collagen; Combined Modality Therapy; Drug Evaluation, Preclinical; Endothelium, Vascular; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Injections; Interleukin-1beta; Male; Myocardial Infarction; Neovascularization, Physiologic; Pravastatin; Random Allocation; Rats; Rats, Zucker; Single-Blind Method; Triglycerides; Ultrasonography; Vascular Endothelial Growth Factor A; Ventricular Remodeling | 2006 |
The HMG-CoA reductase inhibitor, pravastatin, prevents the development of monocrotaline-induced pulmonary hypertension in the rat through reduction of endothelial cell apoptosis and overexpression of eNOS.
Topics: Acetylcholine; Animals; Apoptosis; Blood Pressure; Blotting, Western; Body Weight; Caspase 3; Disease Progression; Endothelial Cells; Heart Function Tests; Heart Rate; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Immunohistochemistry; In Situ Nick-End Labeling; Lung; Male; Monocrotaline; Nitric Oxide Synthase Type III; Nitroprusside; Poisons; Pravastatin; Pulmonary Artery; Rats; Rats, Wistar; Survival; Vasodilator Agents | 2006 |
Chemoprevention by pravastatin, a 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor, of N-methyl-N-nitrosourea-induced colon carcinogenesis in F344 rats.
Topics: Animals; Anticarcinogenic Agents; Bile Acids and Salts; Body Weight; Cholesterol; Colonic Neoplasms; Drinking; Eating; Enzyme Inhibitors; Feces; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Methylnitrosourea; Pravastatin; Rats; Rats, Inbred F344; Sterols | 1996 |
[Assessment of short-term effects of awareness programs and pravastatin therapy on subjects from private clinics at high risk for cardiovascular disease].
Topics: Adult; Aged; Blood Pressure; Body Weight; Cardiovascular Diseases; Cholesterol; Evaluation Studies as Topic; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Pravastatin; Program Evaluation; Risk Factors | 1997 |
Effects of chronic combined treatment with captopril and pravastatin on the progression of insulin resistance and cardiovascular alterations in an experimental model of obesity in dogs.
Topics: Animals; Anticholesteremic Agents; Antihypertensive Agents; Blood Glucose; Blood Pressure; Body Weight; Captopril; Cardiovascular Diseases; Cholesterol; Coronary Vessels; Disease Models, Animal; Disease Progression; Dogs; Drug Therapy, Combination; Heart; Insulin; Insulin Resistance; Linear Models; Male; Multivariate Analysis; Myocardium; Obesity; Pravastatin; Triglycerides | 1998 |
[Comparison of hypercholesterolemic men and women at high risk for atherosclerosis. Study of risk factors and response to pravastatin treatment].
Topics: Adult; Aged; Anticholesteremic Agents; Arteriosclerosis; Blood Pressure; Body Weight; Female; Follow-Up Studies; Humans; Hypercholesterolemia; Male; Middle Aged; Patient Selection; Pravastatin; Risk Factors; Sex Factors | 1998 |
Comparative toxicity of high doses of vastatins currently used by clinicians, in CD-1 male mice fed with a hypercholesterolemic diet.
Topics: Animals; Anticholesteremic Agents; Body Weight; Cholesterol; Cholesterol, Dietary; Dose-Response Relationship, Drug; Fatty Acids, Monounsaturated; Fluvastatin; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Lipids; Liver; Lovastatin; Male; Mice; Mice, Inbred Strains; Organ Size; Pravastatin; Simvastatin; Time Factors; Transaminases; Triglycerides | 1999 |
Limitation of heart growth in neonatal piglets by simvastatin and atorvastatin: comparison with pravastatin.
Topics: Administration, Oral; Animals; Animals, Newborn; Atorvastatin; Blood Pressure; Body Weight; DNA; Heart; Heart Rate; Heart Ventricles; Heptanoic Acids; Mitogen-Activated Protein Kinases; Myocardium; Organ Size; Pravastatin; Proteins; Pyrroles; RNA; Simvastatin; Swine; Water | 2001 |
Prolongation of islet allograft survival in mice by combined treatment with pravastatin and low-dose cyclosporine.
Topics: Animals; Blood Glucose; Body Weight; Cyclosporine; Drug Synergism; Graft Survival; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperglycemia; Immunosuppressive Agents; Islets of Langerhans Transplantation; Kidney; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Pravastatin; Transplantation, Homologous | 2001 |
The effect of pravastatin on serum cholesterol levels in hypercholesterolemic diabetic rabbits.
Topics: Animals; Anticholesteremic Agents; Apolipoproteins; Body Weight; Cholesterol; Coconut Oil; Diabetes Complications; Diabetes Mellitus; Diet, Atherogenic; Disease Models, Animal; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lipoproteins; Male; Naphthalenes; Plant Oils; Pravastatin; Rabbits; Triglycerides | 1991 |
Preliminary dose finding study for subacute toxicological study of pravastatin sodium in monkeys.
Topics: Administration, Oral; Alanine Transaminase; Animals; Anticholesteremic Agents; Aspartate Aminotransferases; Body Temperature; Body Weight; Cholesterol; Diarrhea; Dose-Response Relationship, Drug; Eating; Female; Hematologic Tests; Heptanoic Acids; Macaca fascicularis; Male; Naphthalenes; Organ Size; Pravastatin | 1989 |
Subacute toxicological study in monkeys treated orally with pravastatin sodium for 5 weeks.
Topics: Administration, Oral; Animals; Body Weight; Cholesterol; Diarrhea; Dose-Response Relationship, Drug; Female; Hematologic Tests; Heptanoic Acids; Hypolipidemic Agents; Kidney Function Tests; Liver Function Tests; Macaca fascicularis; Male; Naphthalenes; Organ Size; Pravastatin; Time Factors; Urine | 1989 |
Long term oral administration study of pravastatin sodium to beagles for 104 weeks.
Topics: Animals; Anticholesteremic Agents; Body Weight; Dogs; Electrocardiography; Electroretinography; Estrus; Female; Hematologic Tests; Heptanoic Acids; Kidney Function Tests; Liver Function Tests; Male; Naphthalenes; Occult Blood; Ophthalmoscopy; Organ Size; Pravastatin; Time Factors; Urinalysis | 1989 |